A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
NCT06602479
This study is recruiting at 8 US sites in 6 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this Phase 2 study is to evaluate the safety and efficacy of SC MEDI0618 compared to placebo in participants with episodic migraine.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Migraine
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- AbbVie
- Last updated on ClinicalTrials.gov
- May 19, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 1
- Flourish - Birmingham · Birmingham, AL
California · 2
- The Neurology Center of Southern California - Carlsbad Office · La Jolla, CA
- Clinical Research Institute, LCC · Los Angeles, CA
Florida · 2
- Flourish Research - Miami, LLC dba Flourish Research · Miami, FL
- Santos Research Center, Corp - Tampa · Tampa, FL
South Carolina · 1
- Palmetto Primary Care Physicians Division of Gastroenterology - Summerville · Summerville, SC
Texas · 1
- FutureSearch Trials · Austin, TX
Wisconsin · 1
- The Mind+ Neurology Clinic · Mequon, WI
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.